Int. J. Mol. Sci. 2013, 14(5), 9424-9439; doi:10.3390/ijms14059424

Synthesis, Cytotoxicity, DNA Binding and Apoptosis of Rhein-Phosphonate Derivatives as Antitumor Agents
Man-Yi Ye 1,, Gui-Yang Yao 1,, Jing-Chen Wei 2, Ying-Ming Pan 1,*, Zhi-Xin Liao 3 and Heng-Shan Wang 1,*
State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry & Chemical Engineering of Guangxi Normal University, Guilin 541004, China; E-Mails: (M.-Y.Y.); (G.-Y.Y.)
College of Pharmacy, Guilin Medical University, Guilin 541004, China; E-Mail:
Department of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China; E-Mail:
These authors contributed equally to this work.
Authors to whom correspondence should be addressed; E-Mails: (Y.-M.P.); (H.-S.W.); Tel.: +86-773-2120-958 (Y.-M.P. & H.-S.W.).
Received: 31 January 2013; in revised form: 12 April 2013 / Accepted: 15 April 2013 /
Published: 29 April 2013


: Several rhein-phosphonate derivatives (5ac) were synthesized and evaluated for in vitro cytotoxicity against HepG-2, CNE, Spca-2, Hela and Hct-116 cell lines. Some compounds showed relatively high cytotoxicity. Especially compounds 5b exhibited the strongest cytotoxicity against HepG-2 and Spca-2 cells (IC50 was 8.82 and 9.01 μM), respectively. All the synthesized compounds exhibited low cytotoxicity against HUVEC cells. Further experiments proved that 5b could disturb the cell cycle in HepG-2 cells and induce apoptosis. In addition, the binding properties of a model conjugate 5b to DNA were investigated by methods (UV-Vis, fluorescence, CD spectroscopy). Results indicated that 5b showed moderate ability to interact ct-DNA.
rhein; phosphonate; synthesis; cytotoxicity; apoptosis; DNA binding

1. Introduction

α-Aminophosphonic acids (APAs) and their derivatives are an important class of compounds that exhibited intriguing biological activities [110]. A number of potent antibiotics, herbicides, antitumor agents [1115] and enzyme inhibitors [3] are APAs or their derivatives. Moreover, these compounds have been evaluated as inhibitors of matrix metalloproteinases MMP-1, MMP-2, MMP-3 and MMP-8 [1618]. Some derivatives were found to trigger apoptotic cell death in DOHH-2 cells [1921]. Especially their negligible mammalian toxicity and the fact that they very efficiently mimic aminocarboxylic acids makes them extremely important antimetabolites, which compete with their carboxylic counterparts for the active sites of enzymes and other cell receptors [4,2224]. In recent years, there has been growing interest in the antitumor activities studies on the APAs conjugates [2527], owing to the important role of APAs in living systems as analogs of natural α-amino acids. However, there are far fewer reports about reducing toxicity of derivatives by APAs.

Rhein, a main constituent of rhubarb, is a well-characterized anti-inflammatory agent which has been used for treatment of inflammatory diseases such as osteoarthritis, diabetic nephropathy, etc. [2830]. It has also been reported to display inhibitory effects on the proliferation of human breast, colon, lung, NPC [31], CNS, and glioma cancer cells [3234]. Especially some rhein derivatives induce apoptosis in several cancer cell lines such as human colonic adenocarcinoma cells, promyelocytic leukemia cell (HL-60), human nasopharyngeal carcinoma cells, human breast cancer cells and cervical cancer Ca Ski cells [35,36]. Anthraquinone-based drugs have been shown to possess strong antiperliferative properties, such as mitoxantrone, ametantrone, and anthracycline antibiotics (daunorubicin and doxorubicin), and are used for treatment of varied oncology [37]. However, these clinically used drugs also suffered from frequent cardiotoxicity that limited their applicability [38]. Recently, some analogs of APAs had been synthesized to investigate their antioxidant activities [10]. It was found that antioxidant molecules and enzymes can potentially limit the oxidative injury, but most of them are not readily internalized within myocardial cells, or they cannot reach the right cell compartment to exert their protective effect [39,40]. In addition, Łukasz Berlicki suggested that the N–C–P molecular fragment play an important role in the enhancement of antitumor or antivirus activity of leading compounds and its chemistry offer many possibilities for their structural modification [41].

Based on the above considerations, we postulated that the novel conjugates enhanced the cytotoxicity and reduced the induced toxic on human normal cells. In this paper, we report (a) the synthesis of the rhein derivatives with APAs; (b) DNA binding of 5b; (c) in vitro anti-cancer activity and cell selectivity of synthesized conjugates; (d) and the mechanism of how the novel conjugates killed HepG-2 cells.

2. Results and Discussion

2.1. Chemistry

The syntheses of the phosphonate conjugates 5ac were achieved by a convenient procedure shown in Scheme 1.

O,O′-dialky {[N-(phenylmethylene)-α-amino]-α-(substituted phenyl)methyl}phosphonates 2, obtained by reacting of substituted aromatic ketones 1 with ammonium acetate and O,O′-dialkyl phosphite, were converted easily to O,O′-dialkyl α-amino-α-(substituted phenyl)methyl phosphonate 4 via hydrolysis [42,43]. The α-methyl-substituted aminophosphonates 4 were then coupled with rhein to provide phosphonate conjugates 5 in satisfactory yields.

All of compounds in the series 5 were obtained as yellowish solids after column chromatography. Their structures were fully characterized by 1H-NMR. For example, the corresponding 1H-NMR spectrum showed the carbonyl group leads to a downfield shift of the two phenolic hydroxyls. The two methyleneoxy (OCH2CH3) groups attached with phosphorus appear as three multiplets at 3.30–4.30. The chemical shifts of the two methyl (OCH2CH3) hydrogens were different due to the low rate of environmental exchange caused by the slow rotation of the P–C bond. The structures of 5a and the other analogs were further confirmed by 31P-NMR, EI-MS and elemental analysis.

2.2. Cytotoxicity Effects

The cytotoxicity results of all of the compounds against HepG-2, CNE, Spca-2, Hela, Hct-116 tumor cell lines and HUVEC normal cells lines are listed in Table 1. From these data, all conjugates exhibited good to moderate cytotoxicity. Especially, compound 5b exhibited the strongest cytotoxicity against HepG-2 cells with IC50 8.82 ± 0.95 μM, which is even higher than that of fluorouracil. It was because of more hydrophobicity of 5b compared to 5a and 5c. The partition coefficient values were calculated by using the HyperChem Professional program, and the values (logP) of 5a, 5b and 5c were 2.37, 3.05, 2.75, respectively. However, all compounds 5ac show low cytotoxic effect on the Hela cells. These results showed that these conjugates have selective and significant effect on the cell lines. For comparison, activity of compounds against normal cells (HUVEC) was also examined (Table 1). The results indicated that the anti-proliferative activity of some compounds against cancer cells was much higher than normal cells and maybe one cargo superior to anthracene.

2.3. DNA Binding

Although some evidences suggest that other biological targets, including RNA or proteins, may play some important roles in the daunorubicin and mitoxantrone binding, it is generally accepted that DNA is the primary target [45,46]. Similarly, the interactions between small molecules and DNA are believed to be one of the primary action mechanisms of the antitumor activity. The DNA replication in tumor cells can be blocked via the intercalations of the small molecule between the base pairs of DNA [47,48]. Generally, the active compounds show an approximately planar structure and some hydrophobic characteristics to maximize the intercalations. To investigate their binding properties to DNA, several analytical methods, including UV-Vis, fluorescence and circular dichroism spectroscopies were performed.

2.3.1. UV-Vis Absorption Spectral Analysis

The UV-Vis absorption spectroscopy was primarily employed to probe the binding modes of 5b to the calf thymus DNA (ct-DNA). Rhein belongs to the same class of coplanar anthraquinones as daunorubicin and mitoxantrone, which have been in clinical use over 30 years for the treatment of various tumors [49], which is one kind of DNA targeting agent. Their function as noncovalent DNA binders is generally believed to be essential for their activity. The inherent absorbance of 5b allowed us to investigate its interaction with ct DNA by absorption spectroscopy. The UV-vis absorption spectra of 5b in the absence and presence of ct-DNA are shown in Figure 1 (for 5a and 5c, see Figures S1 and S2). As shown in the figures, the absorbance of 5a, 5b and 5c changed upon addition of DNA. This indicated that DNA is one potential target of 5 as expected. The DNA binding constant Kb was calculated by non-linear fitting according to the Equations (1) [50,51], by which the values of Kb for 5b was found to be 1.2 × 104 M, which is higher than that of 5a (1.05 × 104 M) and 5c (0.85 × 104 M).

2.3.2. Fluorescence Emission Titration

The binding ability of these complexes to ct-DNA was primarily investigated by competitive binding in which they served as an intercalative binding probe in competition with GelRed. GelRed, which is environmentally safe and ultra-sensitive for DNA staining, is a newly developed DNA intercalator to replace the classic DNA intercalator EB. Furthermore, both GelRed and EB bound with ct-DNA emit characteristic fluorescence at 590 nm upon 350 nm UV light excitation [52].

In competitive binding experiments, GelRed and ct-DNA solutions were pre-incubated for 30 min to ensure sufficient interactions. The concentration ratio of GelRed to DNA was set at [GelRed]/[DNA] = 1:10 to ensure sufficient binding sites of DNA for GelRed. The emission spectra of the GelRed–ctDNA system in the absence and presence of 5b were shown in Figure 2 (for that of 5a and 5c, see Figures S3 and S4). GelRed–DNA binary solution system gave a characteristic fluorescence emission at around 590 nm when excited at 350 nm, indicating that GelRed molecules intercalated between the adjacent base pairs of DNA and sufficiently prevented fluorescence quenching by polar solvent molecules. The presence of 5b considerably quenched the fluorescence emission of GelRed with the saturation state achieved at the [5b]/[GelRed] ratio of 8:1.

The quenching ability of 5b to GelRed fluorescence can be quantitively estimated by their respective quenching constant, Kq, which were derived from the Stern-Volmer quenching equation. The Kq value for 5b was 3.2 × 103, exhibiting similar intensive intercalation to DNA as rhein (3.94 × 103) (Figure S5), stronger intensity than 5a (2.02 × 103) and 5c (0.753 × 103) (Figures S3 and S4). Meanwhile, it can also be confirmed that the intercalative binding mode of 5b to DNA was similar to GelRed [53].

2.3.3. Circular Dichroism Spectra

The circular dichroism (CD) is a useful technique to assess whether the nucleic acids undergo conformational changes as a result of complex formation or changes in environmental conditions [54,55]. As indicated in Figure 3, the CD spectra of ct-DNA (1.5 × 10−4 M) showed a positive absorption peak at 280 nm and a negative absorption peak at 245 nm due to π–π base stacking and right-hand helicity, respectively. This was consistent with the characteristic B conformation of DNA [56].

As shown in Figure 3, upon the addition of 5b at a [5b]/[DNA] ratio of 1:10, the CD absorption of ct-DNA showed an obvious decrease in the intensities of both the negative and positive absorption bands (for that of 5a and 5c, see Figures S6 and S7). The percentage decreases in the maximal DNA positive and negative absorption by 5b were 9.78% and 32.2%, respectively. It suggested that 5b might intercalate between the neighboring base pairs of ct-DNA mainly due to the aromatic planarity of the anthraquinones. The decrease in the intensities of both positive and negative bands can usually be observed in the intercalative binding of small molecules to DNA [57]. All these results show clearly that these compounds possess higher DNA binding affinities.

2.4. Apoptosis and Cell Cycle Analysis

2.4.1. Apoptosis

Many anthraquinones such as rhein and emodim induce apoptosis [31,33]. Flow cytometry was used to investigate analog-induced apoptosis and cell death. The compounds (5ac) with cytotoxic effects were investigated for the effects on the apoptosis of HepG-2 cells. To clarify the mechanism of rhein derivative-induced cell death, we determined both early and late apoptosis using annexin V-FITC and PI (Propidium iodide) labeling of live cells. Annexin V binds to phosphatidylserine, which is exposed on the cell membrane and is one of the earliest indicators of cellular apoptosis. PI is used as a DNA stain for both flow cytometry to evaluate cell viability or DNA content in cell cycle analysis and microscopy to visualize the nucleus and other DNA containing organelles. It can be used to differentiate necrotic, apoptotic and normal cells. In the present study, the apoptotic cell rates were determined for the HepG-2 cells after stimulation for 24 h by the compounds at different concentrations. The graphical values of the results were given in Figure 4. From the results, it was found that these compounds stimulated apoptosis for HepG-2 cells compared to negative (unstimulated cells by compounds) controls. Compounds 5a and 5b induced apoptosis in 84.4% and 70.4% of the HepG-2 cells. Compounds 5a and 5b are of special interest as these compounds seem to drive HepG-2 cells directly into early apoptosis. Meanwhile, we also investigated for the effects on the apoptosis of HUVEC cells. The result showed that the compounds we have synthesized had no significant apoptotic effects on HUVEC cells.

2.4.2. Cell Cycle Analysis

The cell cycle is the series of events that take place in a cell leading to its division and duplication (replication). The cell cycle consists of four distinct phases: G1 phase, S phase (synthesis), G2 phase (collectively known as interphase) and M phase (mitosis). The G1 stage is the stage when preparation of energy and material for DNA replication occurs. The S stage is the stage when DNA replication occurs. The G2 stage is the stage when preparation for the M stage occurs. The M stage is “mitosis,” and is when nuclear and cytoplasmic division occurs. Flow-cytometric analysis further confirmed tumor cell apoptosis as shown in Figure 5. Cytometric profiles of the PI-stained DNA showed cell cycle arrest of HepG-2 cells treated with 5a or 5b for 48 h at different concentrations. G2-phase populations of 7.23%, 11.08%, 18.05% for 5a at 20 μM, 30 μM, 40 μM were observed compared with the G2-phase population of 4.27% for untreated cells. For compound 5b, G2-phase populations of 8.52%, 14.56%, 18.23% for 5b at 10 μM, 20 μM, 30 μM were observed compared with the G2-phase population of 4.27% for control (−) cells.

3. Experimental Section

3.1. Chemistry

All chemicals (reagent grade) used were commercially available. NMR spectra were measured on a BRUKER AVANCE AV500 spectrometer using TMS as the internal standard. The mass spectra were obtained on a BRUKER ESQUIRE HCT spectrometer. Melting points were determined using an X-4 apparatus and were uncorrected. Elemental analyses were performed on a Vario Micro Cube Elemental instrument and were within 0.4% of the theoretical values.

General Procedure for the Preparation of Rhein α-Aminophosphonic Acids Conjugates 5

A suspension of aromatic ketones (10 mmol) and ammonium acetate (11 mmol) was stirred for 6 h at reflux. The reaction mixture was filtered to give the white precipitate 2, to which the diethyl phosphite (5 mmol) was added and the resulting solution was stirred for 6 h at 80 °C. After that, hydrochloric acid (4 mmol) in 30 mL ether was added to the reaction mixture, which was stirred for 2 h at 0 °C to give the precipitate 3. The precipitate was filtered and washed with ether (3 × 15 mL), then it was added to 10 mL sodium hydroxide solution (10%) and stirred for 30 min at room temperature. Extraction with dichloromethane (3 × 25 mL) and evaporation of the solvent gave the oils of 4, which was purified by column chromatography on silica gel with ethyl acetate. To a mixture of rhein and HOBt in DMSO (15 mL), the appropriate EDAC was stirred for 15 min at 0 °C. Then 4 was added dropwise with constant stirring at 0 °C, the mixture was stirred at ambient temperature for another 10 h, then washed with brine, dried with anhydrous sodium sulfate and evaporated. The residue was purified by column chromatography on silica gel with petroleum ether/ethyl acetate (3:1, v:v) to give the pure title compounds 5 as yellowish solids.

O,O-Diethyl{[2-(4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene)acetamido] (4-tolyl) ethyl} phosphonate (5a). Yield 78%. m.p. 132~134 °C. 1H-NMR (500 MHz CDCl3) δ (ppm):0.88 (t, J = 6.5 Hz, 3H, CH3), 1.31 (t, J = 7.0 Hz, 3H, CH3), 2.20 (d, 3J (P,H) = 16.0 Hz, 3H, CH3), 2.33 (s, 3H, Ar-CH3), 3.72–4.05 (m, 4H, OCH2), 7.16–8.16 (m, 10H, Ar-H, 1H, NH), 11.99 (s, 1H, OH), 12.06 (s, 1H, OH). 31P{H} NMR(202 MHz, CDCl3) δ (ppm): 24.18. ESI-MS m/z: 560.2 (M+Na)+. Anal. Calc. (for C28H28NO8P+H2O): C, 62.57; H, 5.25; N, 2.61; Found: C, 60.57; H, 5.44; N, 2.52.

O,O-Diethyl{[2-(4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene)acetamido] (Phenylethyl) ethyl} phosphonate (5b). Yield 71%. m.p. 119~121 °C. 1H-NMR (500 MHz CDCl3) δ (ppm): 0.87 (t, J = 6.3 Hz, 3H, CH3), 1.39 (t, J = 7.1 Hz, 3H, 2×CH3), 1.83 (d, 3J (P,H) = 16.0 Hz, 3H, CH3), 2.32–2.81 (m, 4H, OCH2), 4.24 (m, 4H, CH2), 6.52 (d, J = 5.71 Hz, 1H, NH), 7.13–8.04 (m, 10H, Ar-H), 11.95 (s, 1H, OH), 12.01 (s, 1H, OH). 31P{H} NMR (202 MHz, CDCl3) δ (ppm): 26.67. ESI-MS m/z: 574.2(M+Na)+. Anal. Calc. (for C29H30NO8P+H2O): C, 63.15; H, 5.48; N, 2.54; Found: C, 61.16; H, 5.66; N, 2.46.

O,O-Diethyl {[2-(4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene) acetamido] (phenyl) methyl} phosphonate (5c). Yield 78%. m.p. 141~143 °C. 1H-NMR (500 MHz CDCl3) δ (ppm): 1.23 (t, J = 6.9 Hz, 3H, CH3), 1.30 (t, J = 6.9 Hz, 3H, CH3), 2.23 (d, 3J (P,H) = 15.9 Hz, 3H, CH3), 3.71–4.06 (m, 4H, OCH2), 7.26–8.16 (m, 10H, Ar-H, 1H, NH), 11.98 (s, 1H, OH),12.06 (s, 1H, OH). 31P{H} NMR (202 MHz, CDCl3) δ (ppm): 24.07. ESI-MS m/z: 546.2 (M+Na)+. Anal. Calc. (for C27H26NO8P+H2O): C, 61.95; H, 5.01; N, 2.68; Found: C, 59.89; H, 5.21; N, 2.59.

3.2. Biological Assays

3.2.1. Cytotoxicity of Rhein Derivatives Cell Lines

The following in vitro human cancer cell lines were used: HepG 2 (human epidermoid larynx carcinoma), Hela (Henrietta Lacks strain of cancer cells), Hct-116 (human colorectal cells), CNE (human nasopharyngeal carcinoma cells), Spca-2 (human lung adenocarcinoma cell line), HUVEC (human umbilical vein endothelial cells). The cell lines (HepG 2, Hela, Hct-116, CNE, Spca-2, HUVEC) were purchased from the Cell Resource Center of Shanghai Institutes for Biological Sciences, The Academy of Sciences of China. Cell Culture

HepG-2, Hela, Hct-116, CNE, HUVEC cells were cultured in Dulbecco Modified Eagle Medium (DMEM) (Thermo), containing 4.0 mM l-Glutamine and 4,500 mg/L Glucose, supplemented with 10% (v/v) fetal bovine serum (FBS; HyClone, Logan, UT, USA). Spca-2 cells were cultured in RPMI-1640 medium, containing 2.05 mM l-Glutamine without Calcium nitrate, supplemented with 10% (v/v) fetal bovine serum (FBS; HyClone). The cell culture media was supplemented with penicillin/streptomycin at 100 Units/mL as adherent monolayers. Cell cultures were kept in a humidified incubator with 5% CO2 at 37 °C. Stock solutions were prepared in dimethyl sulfoxide (DMSO) and further dilutions were made with fresh culture medium. The concentration of DMSO in the final culture medium was 1%, which had no effect on the cell viability. MTT Assay

Chemosensitivity was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Briefly, exponentially growing HepG-2 (2,000–3,000 cells/well), Hela (2,000–3,000 cells/well), Hct-116 (3,000–4,000 cells/well), CNE (2,000–3,000 cells/well), HUVEC (2,000–3,000 cells/well) and Spca-2 (2,000–3,000 cells/well) were seeded into 96-well plates and treated with indicated concentrations of samples for 48h, and then 10 mL of MTT (10 mg/mL) was added. After incubation for 4 h at 37 °C, the purple formazan crystals (i.e., a reduced form of MTT) generated from viable cells were dissolved by adding 100 μL DMSO in each well. The plates were swirled gently for 10 min to dissolve the precipitate, and quantified by measuring the optical density (OD) of the plates at a wavelength of 490 nm on plate reader (TECAN infinite M1000). Each concentration was repeated in three wells and the same experimental conditions were provided for all compounds and MTT analysis was repeated three times for each cell line.

3.2.2. Determination of Apoptosis and Cell Cycle Analysis Apoptosis Analysis

Apoptosis was discriminated with the annexin V-FITC/propidium iodide test. Cells were seeded at 2 × 106/well in 10% FBS-DMEM into 6-well plates, and treated with compounds for 24 h. The cells were washed twice with cold phosphate buffered saline (PBS) and then resuspended in 1× Binding Buffer (0.1 M Hepes/NaOH (pH 7.4), 1.4 M NaCl, 25 mM CaCl2) at a concentration of 1 × 106 cells/mL. The transfer of 100 μL of the solution (1 × 105 cells) to a 5 mL culture tube was made, and 5 μL of FITC annexin V (BD, Pharmingen) and 5 μL propidium iodide (PI) were added to each tube. The cells were gently vortexed and incubated for 30 min at RT (25 °C) in the dark. Two hundred μL PBS were added to each tube. Analysis was performed with the system software (CellQuest; BD Biosciences, Mountain View, CA, USA). Lower left quadrant, viable cells (annexin V−/PI−); lower right quadrant, early apoptotic cells (annexin V+/PI−); upper right quadrant, late apoptotic cells (annexin V+/PI+); upper left quadrant, necrotic cells (annexin V−/PI+). The percentage of cells positive for PI and/or annexin V-FITC was reported inside the quadrants. Cell Cycle Analysis

The cell lines were treated with indicated concentrations of compounds. After being incubated for 48 h, cells were washed twice with ice-cold PBS, fixed and permeabilized with ice-cold 70% ethanol at −20 °C overnight. The cells were treated with 100 μg/mL RNase A at 37 °C for 30 min after washed with ice-cold PBS, and finally stained with 1 mg/mL propidium iodide (PI) in the dark at 4 °C for 30 min. Analysis was performed with the system software (CellQuest; BD Biosciences).

3.2.3. Spectroscopic Studies on DNA Interaction

The 2 × 10−3 M ct-DNA stock solution was stored at 4 °C for no more than 5 days before use. The synthesized conjugate (5b) was prepared as 2 × 10−3 M DMSO stock solutions for DNA binding studies. The final working solutions of the complexes for DNA binding studies were diluted by TBS and the DMSO content was less than 10%. For UV-vis absorption experiments, the working solutions of the complexes were kept constant at 25 μM. The ct-DNA stock solution was increasingly added until a saturation state was achieved. After each addition, the solution was allowed to incubate for 5 min before the absorption spectra were recorded. Kb as the equilibrium DNA binding constant and s as the binding site size were determined by non-linear fitting according to Equation (1) [50,51]:

( ɛ a - ɛ f ) / ( ɛ b - ɛ f ) = ( b - ( b 2 - 2 K b 2 C t [ D N A ] / s ) 1 / 2 ) / 2 K b C t

where [DNA] is the DNA concentration in nucleotides, ɛa is the molar extinction coefficient of the compound bound with DNA, ɛf is the extinction coefficient of the free compound, and ɛb is the extinction coefficient of the compound fully bound to DNA. ɛa, ɛf and ɛb are all calculated from the Lambert-Beer’s law (ɛ = A/[compound]). To determine ɛb, it is assumed that the compounds are fully bound with DNA at the point where no further hypochromicity is observed under the addition of ct-DNA, and the apparent absorbance Ab is regarded as the absorbance of only the bound compounds. Ct is the constant concentration of the compounds, and s is the number of binding sites in base pairs. A solution containing 2 × 10−4 M DNA and 2 × 10−5 M GelRed ([DNA]/[GelRed] = 10:1) was prepared for GelRed-DNA competitive binding studies. Fluorescence emission spectra were recorded under slit width as 10 nm/10 nm for Ex/Em, respectively. The quenching constant for comparing the efficiency of fluorescence quenching, i.e., Kq, of each compound was obtained by the linear fit of plotting I0/I versus [Q], according to the classic Stern-Volmer equation: I0/I = 1 + Kq × [Q] [58], where I0 and I are the peak emission intensity of the GelRed-DNA system in the absence and presence of each compound as quencher, and [Q] is the concentration of quencher. In the fluorescence polarization experiment, each sample was pre-incubated for 40 min before the fluorescence polarization was recorded under the condition of 595 nm emitting wavelength with 350 nm exciting wavelength, and slit width was set as 5 nm/5 nm for Ex/Em, respectively. CD absorption spectra of DNA were measured in TBS at a 100 nm/min scan rate in the wavelength range from 200 to 400 nm, with 1 × 10−4 M DNA in the absence and presence of each compound of 2 × 10−5 M, respectively. The CD signal of TBS was taken as the background and subtracted from the spectra. All the spectroscopic experiments were performed at 25 °C.

3.3. Statistics

The data were processed by the Student’s t-test with the significance level p ≤ 0.05 using SPSS.

4. Conclusions

Cancer is a leading cause of death worldwide and hence studies to find anti-cancer agents for its treatment continue to grow in importance. In the present study, as potential anti-cancer agents, rhein-phosphorus derivatives were synthesized and characterized by mass spectrometry, 1H and 31P-NMR spectroscopy. It was detected that the compounds 5a and 5b had selective and significant cytotoxic effects on HepG-2 cells, respectively. Especially compounds 5b exhibited the strongest cytotoxicity against HepG-2 and Spca-2 cells with IC50 8.82 and 9.01 μM, respectively. In addition, it was found that 5a and 5b disturbed the cell cycle and induced apoptosis in HepG-2 cells and the toxic of all conjugates were lower than rhein. The binding properties of 5b to DNA examined by various methods indicated that 5b interacted with DNA. Therefore, these compounds may be considered as the agents with high potential anti-cancer activity and appear to be good candidates for more advanced screening.

Supplementary Information


This study was supported by 973 Project (No. 2011CB512005, 2012CB723501), the National Natural Science Foundation of China (No. 81260472, 21101035), Guangxi Natural Science Foundation of China (No. 2011GXNSFD018010 and No. 2010GXNSFF013001), Bagui Scholar project and the Foundation of Ministry of Education Innovation Team (NO. IRT1225).

Conflict of Interest

The authors declare no conflict of interest.


  1. Mandhanea, P.G.; Joshia, R.S.; Nagargojea, D.R.; Chatea, A.V.; Gilla, C.H. Ultrasonic promoted synthesis and antibacterial screening of some novel piperidine incorporated α-aminophosphonates. Phosphorus Sulfur Silicon Relat. Elem 2010, 186, 149–158.
  2. Reddy, S.S.; Rao, V.K.; Krishna, B.S.; Reddy, C.S.; Visweswara, P.R.; Raju, C.N. Synthesis, antimicrobial, and antioxidant activity of new α-aminophosphonates. Phosphorus Sulfur Silicon Relat. Elem 2011, 186, 1411–1421.
  3. Liu, W.; Rogers, C.J.; Fisher, A.J.; Toney, M.D. Aminophosphonate inhibitors of dialkylg-lycine decarboxylase: Structural basis for slow binding inhibition. Biochemistry 2002, 41, 12320–12328.
  4. Kafarski, P.; Lejczak, B. Aminophosphonic acids of potential medical importance. Curr. Med. Chem. Anticancer Agents 2001, 1, 301–312.
  5. Jin, L.H.; Song, B.A.; Zhang, G.P.; Xu, R.Q.; Zhang, S.M.; Gao, X.W.; Hu, D.Y.; Yang, S. Synthesis, X-ray crystallographic analysis, and antitumor activity of N-(benzothiazole-2-yl)-1-(fluorophenyl)-O,O-dialkyl-α-aminophosphonates. Bioorg. Med. Chem. Lett 2006, 16, 1537–1543.
  6. Kudzin, Z.H.; Kudzin, M.H.; Drabowicz, J.; Stevens, C.V. Aminophosphonic acids—Phosphorus analogues of natural amino acids. Part 1: Syntheses of α-aminophosphonic acids. Curr. Org. Chem 2011, 15, 2015–2071.
  7. Orsini, F.; Sello, G.; Sisti, M. Aminophosphonic acids and derivatives. Synthesis and biological applications. Curr. Med. Chem 2010, 17, 264–289.
  8. Kukhar, V.P.; Hudson, H.R. Aminophosphonic and Aminophosphinic Acids: Chemistry and Biological Activity. In Aminophosphonic and Aminophosphinic Acids: Chemistry and Biological Activity; John Wiley: New York, NY, USA, 2000.
  9. Naydenova, E.; Troev, K.; Topashka-Ancheva, M.; Hägele, G.; Ivanov, I.; Kril, A. Synthesis, cytotoxicity and clastogenicity of novel α-aminophosphonic acids. Amino Acids 2007, 33, 695–702.
  10. Naydenova, E.D.; Todorov, P.T.; Troev, K.D. Recent synthesis of aminophosphonic acids as potential biological importance. Amino Acids 2010, 38, 23–30.
  11. Flors, V.; Miralles, C.; Gonzalez-Bosch, C.; Carda, M.; Garcia-Agustin, P. Molecular cloning and characterization of an intestinal cathepsin L protease from the plant-parasitic nematode Meloidogyne incognita. Physiol. Mol. Plant Pathol 2003, 63, 151–158.
  12. Paula, V.F.; Barbosa, L.C.; Demuner, A.J.; Piló-Veloso, D.; Picanço, M.C. Synthesis and insecticidal activity of new amide derivatives of piperine. Pest Manag. Sci 2000, 56, 168–174.
  13. Lamberth, C.; Kempf, H.J.; Kriz, M. Synthesis and fungicidal activity of N-2-(3-methoxy-4-propargyloxy) phenethyl amides. Part 3: Stretched and heterocyclic mandelamide oomyceticides. Pest Manag. Sci 2007, 63, 57–62.
  14. Jennings, L.D.; Rayner, D.R.; Jordan, D.B.; Okonys, J.F.; Basarab, G.S.; Amorose, D.K.; Anaclerio, B.M.; Lee, J.K. Cyclobutane carboxamide inhibitors of fungal melanin: Biosynthesis and their evaluation as fungicides. Bioorg. Med. Chem 2000, 8, 897–907.
  15. Navickiene, H.M.D.; Miranda, J.E.; Bortoli, S.A.; Kato, M.J.; Bolzani, V.S.; Furlan, M. Toxicity of extracts and isobutyl amides from Piper tuberculatum: Potent compounds with potential for the control of the velvetbean caterpillar, Anticarsia gemmatalis. Pest Manag. Sci 2007, 63, 399–403.
  16. Caldweu, C.G.; Sahoo, S.P.; Polo, S.A.; Eversole, R.R.; Lanza, T.J.; Mills, S.G.; Niedzwiecki, L.M.; Izquierdo-Martin, M.; Chang, B.C.; Harrison, R.K.; et al. Phosphinic acid inhibitors of matrix metalloproteinases. Bioorg. Med. Chem. Lett 1996, 6, 323–328.
  17. Bianchini, G.; Aschi, M.; Cavicchio, G.; Crucianelli, M.; Preziuso, S.; Gallina, C.; Nastari, A.; Gavuzzo, E.; Mazza, F. Design, modelling, synthesis and biological evaluation of peptidomi-metic phosphinates as inhibitors of matrix metalloproteinases MMP-2 and MMP-8. Bioorg. Med. Chem 2005, 13, 4740–4749.
  18. Pochetti, G.; Gavuzzo, E.; Campestre, C.; Agamennone, M.; Tortorella, P.; Consalvi, V.; Carlo, G.; Hiller, O.; Tschesche, H.; Tucker, P.A.; et al. Structural insight into the stereo-selective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates. J. Med. Chem 2006, 49, 923–931.
  19. Naydenova, E.; Topashka-Ancheva, M.; Todorov, P.; Yordanova, T.; Troev, K. Novel α-aminophosphonic acids. Design, characterization, and biological activity. Bioorg. Med. Chem 2006, 14, 2190–2196.
  20. Naydenova, E.; Vassilev, A.; Popova, Y.; Troev, K. Phosphonylmethylaminocyclopentane-1-carboxylic acid. Heteroat. Chem 2003, 14, 229–230.
  21. Naydenova, E.; Todorov, P.; Topashka-Ancheva, M.; Momekov, G.; Yordanova, T.; Konstantinov, S.; Troev, K. Novel N-(phosphonomethyl) glycine derivatives: Design, characterization and biological activity. Eur. J. Med. Chem 2008, 43, 1199–1205.
  22. Meek, T.D.; Villafranca, J.J. Kinetic mechanism of Escherichia coli glutamine synthetase. Biochemistry 1980, 19, 5513–5519.
  23. Oleksyszyn, J.; Boduszek, B.; Kam, C.M.; Powers, J.C. Novel amidine-containing peptidyl phosphonates as irreversible inhibitors for blood coagulation and related serine proteases. J. Med. Chem 1994, 37, 226–231.
  24. Logusch, E.W.; Walker, D.M.; McDonald, J.F.; Franz, J.E.; Villafranca, J.J.; DiIanni, C.L.; Colanduoni, J.A.; Schineller, J.B. Inhibition of Escherichia coli glutamine synthetase by alpha- and gamma-substituted phosphinothricins. Biochemistry 1990, 29, 366–372.
  25. Kuo, R.Y.; Qian, K.; Morris-Natschke, S.L.; Lees, K.H. Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents. Nat. Prod. Rep 2009, 26, 1321–1344.
  26. Deng, S.L.; Baglin, I.; Nour, M.; Cavé, C. Synthesis of phosphonodipeptide conjugates of ursolic acid and their homologs. Heteroat. Chem 2008, 19, 55–65.
  27. Deng, S.L.; Baglin, I.; Nour, M.; Flekhter, O.; Vita, C.; Cavé, C. Synthesis of ursolic phosphonate derivatives as potential anti-HIV agents. Phosphorus Sulfur Silicon Relat. Elem 2007, 182, 951–967.
  28. Cai, Y.; Sun, M.; Xing, J.; Corke, H. Antioxidant phenolic constituents in roots of Rheum officinale and Rubia cordifolia: Structure-radical scavenging activity relationships. J. Agric. Food Chem 2004, 52, 7884–7890.
  29. Gao, Q.; Qin, W.S.; Jia, Z.H.; Zheng, J.M.; Zeng, C.H.; Li, L.S.; Liu, Z.H. Rhein improves renal lesion and ameliorates dyslipidemia in db/db mice with diabetic nephropathy. Planta Med 2010, 76, 27–33.
  30. Tamura, T.; Shirai, T.; Kosaka, N.; Ohmori, K.; Takafumi, N. Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption. Eur. J. Pharmacol 2002, 448, 81–87.
  31. Cai, J.; Duan, Y.B.; Yu, J.; Chen, J.Q.; Chao, M.; Ji, M. Bone-targeting glycol and NSAIDS ester prodrugs of rhein: Synthesis, hydroxyapatite affinity, stability, anti-inflammatory, ulcerogenicity index and pharmacokinetics studies. Eur. J. Med. Chem 2012, 55, 409–419.
  32. Lin, M.L.; Chung, J.G.; Lu, Y.C.; Yang, C.Y.; Chen, S.S. Rhein inhibits invasion and migration of human nasopharyngeal carcinoma cells in vitro by down-regulation of matrix metalloproteinases-9 and vascular endothelial growth factor. Oral Oncol 2009, 45, 531–537.
  33. Raimondi, F.; Santoro, P.; Maiuri, L.; Londei, M.; Annunziata, S.; Ciccimarra, F. Reactive nitrogen species modulate the effects of rhein, an active component of senna laxatives, on human epithelium in vitro. J. Pediatr. Gastroenterol. Nutr 2002, 34, 529–534.
  34. Lin, S.; Fu, J.M.; Hou, D.X. Rhein induces apoptosis in HL-60 cells via reactive oxygen species-independent mitochondrial death pathway. Arch. Biochem. Biophys 2003, 418, 99–107.
  35. Ip, S.W.; Weng, Y.S.; Lin, S.Y.; Mei, D.; Tang, N.Y.; Su, C.C. The role of Ca2+ on rhein induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 2007, 27, 379–389.
  36. Lin, M.L.; Chen, S.S.; Lu, Y.C.; Liang, R.Y.; Ho, Y.T.; Yang, C.Y. Rhein induces apoptosis through induction of endoplasmic reticulum stress and Ca2+-dependent mitochondrial death pathway in human nasopharyngeal carcinoma cells. Anticancer Res 2007, 27, 3313–3322.
  37. Tarasiuk, J.; Mazerski, J.; Tkaczyk-Gobis, K.; Borowski, E. Molecular basis of the low activity of antitumor anthracenediones, mitoxantrone and ametantrone, in oxygen radical generation catalyzed by NADH dehydrogenase. Enzymatic and molecular modelling studies. Eur. J. Med. Chem 2005, 40, 321–328.
  38. Shchekotikhin, A.E.; Glazunova, V.A.; Dezhenkova, L.G.; Luzikov, Y.N.; Sinkevich, Y.B.; Kovalenko, L.V.; Buyanov, V.N.; Balzarini, J.; Huang, F.C.; Lin, J.J.; et al. Synthesis and cytotoxic properties of 4,11-bis(aminoethyl)aminoanthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones. Bioorg. Med. Chem 2009, 17, 1861–1869.
  39. Mucha, A.; Kafarski, P.; Berlicki, Ł. Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry. J. Med. Chem 2011, 54, 5955–5980.
  40. Jolly, S.R.; Kane, W.J.; Bailie, M.B.; Abrams, G.D.; Lucchesiet, B.R. Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase. Circ. Res 1984, 54, 277–285.
  41. Omar, B.A.; Flores, S.C.; McCord, J.M. Superoxide dismutase: Pharmacological develop-ments and applications. Adv. Pharmacol 1992, 21, 109–161.
  42. Kaboudin, B.; Moradi, K. A simple and convenient procedure for the synthesis of 1-amino-phosphonates from aromatic aldehydes. Tetrahedron Lett 2005, 46, 2989–2991.
  43. Sara, S.; Zahra, T. Al(OTf)3 as an efficient catalyst for one-pot synthesis of primary diethyl 1-aminophosphonates under solvent-free conditions. Synth. Commun 2008, 39, 120–131.
  44. Sharma, R.I.; Smith, T.A.D. Colorectal tumor cells treated with 5-FU, oxaliplatin, irinotecan, and cetuximab exhibit changes in 18F-FDG incorporation corresponding to hexokinase activity and glucose transport. J. Nucl. Med 2008, 49, 1386–1394.
  45. Cashman, D.J.; Kellogg, G.E. A computational model for anthracycline binding to DNA: Tuning groove-binding intercalators for specific sequences. J. Med. Chem 2004, 47, 1360–1374.
  46. Tan, J.H.; Zhang, Q.X.; Huang, Z.S.; Chen, Y.; Wang, X.D.; Gu, L.Q.; Wu, J.Y. Synthesis, DNA binding and cytotoxicity of new pyrazole emodin derivatives. Eur. J. Med. Chem 2006, 41, 1041–1047.
  47. Dutta, S.; Abe, H.; Aoyagi, S.; Kibayashi, C.; Gates, K.S. DNA damage by fasicularin. J. Am. Chem. Soc 2005, 127, 15004–15005.
  48. Tanaka, K.; Yamada, Y.; Shionoya, M. Formation of silver(I)-mediated DNA duplex and triplex through an alternative base pair of pyridine nucleobases. J. Am. Chem. Soc 2002, 124, 8802–8803.
  49. Monneret, C. Recent developments in the field of antitumour anthracyclines. Eur. J. Med. Chem 2001, 36, 483–493.
  50. Carter, M.T.; Rodriguez, M.; Bard, A.J. Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt(III) and iron(II) with 1,10-phenanthroline and 2,2′-bipyridine. J. Am. Chem. Soc 1989, 111, 8901–8911.
  51. Liu, X.W.; Li, J.; Li, H.; Zheng, K.C.; Chao, H.; Ji, L.N. Synthesis, characterization, DNA-binding and photocleavage of complexes Ru(phen)2(6-OH-dppz)2+ and Ru(phen)2(6-NO2-dppz)2+. J. Inorg. Biochem 2005, 99, 2372–2380.
  52. Liu, M.; Zhao, H.M.; Chen, S.; Yu, H.T.; Zhang, Y.B.; Quan, X. Label-free fluorescent detection of Cu(II) ions based on DNA cleavage-dependent graphene-quenched DNAzymes. Chem. Commun 2011, 47, 7749–7751.
  53. Zhang, G.; Guo, J.; Zhao, N.; Wang, J. Study of interaction between kaempferol-Eu3+ complex and DNA with the use of the neutral red dye as a fluorescence probe. Sens. Actuators B Chem 2010, 144, 239–246.
  54. Mahadevan, S.; Palaniandavar, M. Spectroscopic and voltammetric studies on copper complexes of 2,9-dimethyl-1,10-phenanthrolines bound to calf thymus DNA. Inorg. Chem 1998, 37, 693–700.
  55. Rajendiran, V.; Murali, M.; Suresh, E.; Palaniandavar, M.; Periasamy, V.S.; Akbarsha, M.A. Non-covalent DNA binding and cytotoxicity of certain mixed-ligand ruthenium(II) complexes of 2,2-dipyridylamine and diimines. Dalton Trans. 2008, 2157–2170.
  56. Schäfe, S.; Gust, I.; Ott, R.; Sheldrick, W.S. Influence of the polypyridyl (pp) ligand size on the DNA binding properties, cytotoxicity and cellular uptake of organoruthenium(II) complexes of the type (η6-C6Me6) Ru(L)(pp)n+ L = Cl, n = 1; L = (NH2)2CS, n = 2. Eur. J. Inorg. Chem 2007, 19, 3034–3046.
  57. Xu, H.; Zheng, K.C.; Chen, Y.; Li, Y.Z.; Lin, L.J.; Li, H.; Zhang, P.X.; Ji, L.N. Effects of ligand planarity on the interaction of polypyridyl Ru(II) complexes with DNA. Dalton Trans. 2003, 2260–2268.
  58. Ghosh, S.; Barve, A.C.; Kumbhar, A.A.; Kumbhar, A.S.; Puranik, V.G.; Datar, P.A.; Sonawane, U.B.; Joshi, R.R. Synthesis, characterization, X-ray structure and DNA photocleavage by cis-dichloro bis(diimine) Co(III) complexes. J. Inorg. Biochem 2006, 100, 331–343.
Ijms 14 09424f1 200
Figure 1. UV-Vis absorption spectra of complex 5b in the absence (---) and presence (—) of ct-DNA with increasing [DNA]/[5b] ratios in the range from 1:1 to 10:1.

Click here to enlarge figure

Figure 1. UV-Vis absorption spectra of complex 5b in the absence (---) and presence (—) of ct-DNA with increasing [DNA]/[5b] ratios in the range from 1:1 to 10:1.
Ijms 14 09424f1 1024
Ijms 14 09424f2 200
Figure 2. Fluorescence emission spectra of GelRed bound with ct-DNA ([DNA] = 2.0 × 10−3 M, [GelRed] = 2.0 × 10−3 M) in the absence (dash line) and presence (solid lines) of 5b with [5b]/[GelRed] ratios range from 1:2 to 7.5:1. Inset: linear fitting for quenching constant Kq based on Stern-Volmer equation.

Click here to enlarge figure

Figure 2. Fluorescence emission spectra of GelRed bound with ct-DNA ([DNA] = 2.0 × 10−3 M, [GelRed] = 2.0 × 10−3 M) in the absence (dash line) and presence (solid lines) of 5b with [5b]/[GelRed] ratios range from 1:2 to 7.5:1. Inset: linear fitting for quenching constant Kq based on Stern-Volmer equation.
Ijms 14 09424f2 1024
Ijms 14 09424f3 200
Figure 3. CD spectra of ct-DNA (2 mL solution, 1.5 × 10−4 M) in the absence and presence of 5b (1.5 × 10−5 M).

Click here to enlarge figure

Figure 3. CD spectra of ct-DNA (2 mL solution, 1.5 × 10−4 M) in the absence and presence of 5b (1.5 × 10−5 M).
Ijms 14 09424f3 1024
Ijms 14 09424f4 200
Figure 4. Effect of cyclotriphosphazene compounds on apoptosis of HepG-2 and HUVEC cells. Apoptotic cells were analyzed by flow cytometry, after being stained with annexin V-FITC together with PI. The percentage of cells positive for PI and/or annexin V-FITC are reported inside the quadrants.

Click here to enlarge figure

Figure 4. Effect of cyclotriphosphazene compounds on apoptosis of HepG-2 and HUVEC cells. Apoptotic cells were analyzed by flow cytometry, after being stained with annexin V-FITC together with PI. The percentage of cells positive for PI and/or annexin V-FITC are reported inside the quadrants.
Ijms 14 09424f4 1024
Ijms 14 09424f5 200
Figure 5. Inhibition of cell cycle progress in HepG-2 cells treated with 5a and 5b for 48 h. Cells were fixed with ethanol and stained with PI. Cell cycle distribution was analyzed by flow cytometry.

Click here to enlarge figure

Figure 5. Inhibition of cell cycle progress in HepG-2 cells treated with 5a and 5b for 48 h. Cells were fixed with ethanol and stained with PI. Cell cycle distribution was analyzed by flow cytometry.
Ijms 14 09424f5 1024
Ijms 14 09424f6 200
Scheme 1. General synthetic route for compound 5ac.

Click here to enlarge figure

Scheme 1. General synthetic route for compound 5ac.
Ijms 14 09424f6 1024
Table 1. IC50a values (μM) of rhein and complexes 5ac towards five selected tumor cell lines and normal cell lines for 72 h.

Click here to display table

Table 1. IC50a values (μM) of rhein and complexes 5ac towards five selected tumor cell lines and normal cell lines for 72 h.
5ap-Ph-CH315.11 ± 1.5433.75 ± 2.1716.94 ± 1.32>5030.64 ± 8.75>100
5bEthylbenzene8.82 ± 0.9527.27 ± 3.789.01 ± 0.8745.3612.66 ± 1.50>100
5cPh18.23 ± 1.8738.34 ± 8.2325.12 ± 2.72>5023.44 ± 3.22>100
Rhein38.34 ± 6.34>5028.31 ± 1.40>50>5079.74 ± 5.40
5-Fu20.30 ± 2.43>50No Date>504.3 ± 0.52 [44]No Date

aIC50 values are presented as the mean ± SD (standard error of the mean) from three independent experiments.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert